A researcher can give people a small dose of a gut-hormone fragment and reliably trigger panic-like symptoms. A drug built to block that exact target still failed to treat panic disorder.
Part 14 of the Brain Chemistry series. New here? Start with Your Brain Is Not a Gas Tank, the short orientation that explains the four questions every article in this series answers.
What to know
- Cholecystokinin, or CCK, is a chemical messenger with two jobs. In the gut it helps you digest food and feel full. In the brain and nervous system it acts as a signal between nerve cells.
- A lab-made fragment called CCK-4 can trigger fast panic-like symptoms when researchers give it to volunteers. That is a real, repeatable finding.
- A drug called CI-988 was built to block the same receptor CCK-4 acts on. It did not beat placebo for generalized anxiety disorder, and its panic disorder trial was stopped early for lack of benefit. It also failed to prevent the CCK-4 panic response in a separate study.
- No test measures CCK activity in your brain. Blood tests only reflect what CCK is doing in the body, not in your fear circuits.
- No medicine approved for any mental health condition works by directly targeting CCK. The only approved drug that acts directly on this system, sincalide, is used for gut tests, not for anxiety or panic.
The short answer
Cholecystokinin is a small protein-like messenger the body makes in two settings. Cells in your small intestine release it after you eat fat or protein. It travels through the blood and along a nerve called the vagus nerve to help your gallbladder squeeze, your pancreas release digestive fluid, your stomach empty more slowly, and your brain register that a meal is ending. Separately, nerve cells throughout the brain and gut make their own CCK and use it as a local signal between neighboring cells.
CCK acts through two receptors, called CCK1 and CCK2. CCK1 leans toward digestion and the gut-brain nerve pathway. CCK2 is spread widely through the brain and also responds to a related gut hormone called gastrin. Neither receptor belongs only to the gut or only to the brain, so a single blood test cannot tell you what either one is doing where it matters most.23
The interesting part of this story is a small fragment of CCK called CCK-4. When researchers inject it, many people feel a sudden wave of panic-like symptoms within a minute or two: racing heart, shortness of breath, dizziness, fear. This is one of the most reliable ways scientists have to study a panic response in a lab. It does not mean that everyday panic disorder is caused by too much CCK circulating in the brain. A brief, artificial dose that reliably triggers alarm signals is a different thing from a slow-building illness that appears without a lab injection.
That distinction matters because it was tested directly. If blocking CCK2 could stop panic, a CCK2-blocking drug should work as a treatment. One did get tested, and it did not work.
CCK’s clearest job is digestion. After fat or protein reaches your upper small intestine, specialized cells release CCK. It contracts your gallbladder to release bile, tells your pancreas to release digestive fluid, slows how fast your stomach empties, and signals your brain, partly through the vagus nerve, that a meal is winding down. This is one part of a much larger system. Other hormones, stomach stretch, food type, learned habits, mood, and medicines all shape hunger and fullness too. CCK is one voice in a large committee, not the only one.
Separately, nerve cells package CCK into small storage capsules and release it as a local signal, sometimes alongside another chemical messenger called GABA. This neural CCK changes how nearby brain and gut nerve cells behave. It is part of normal circuit activity, not a leak from the digestive system. Gut CCK does not need to flood into the brain to have an effect there either: the vagus nerve can carry a fullness signal from the gut straight to the brainstem, which is one more reason a blood CCK level cannot tell you what is happening in a brain circuit tied to fear.
Meet the two CCK receptors
CCK1 and CCK2 are often described as “the gut one” and “the brain one.” That is a useful starting point, but both receptors show up in more places than that label suggests.2
| Receptor | What it does, where it matters most, and why you might care |
|---|---|
| CCK1 | What it does: Turns on a calcium-based signal inside the cell it reaches. Where it matters most: Gallbladder, pancreas, stomach, vagus nerve, and some brain sites. Why you might care: Behind digestion, meal-ending signals, and some nausea or discomfort. Sincalide, the one approved CCK-like drug, works mainly here. |
| CCK2 | What it does: Turns on a similar calcium-based signal; also responds to gastrin. Where it matters most: Cortex, limbic brain regions, hypothalamus, brainstem, and stomach. Why you might care: The receptor CCK-4 acts through in panic-challenge research. CI-988 was built to block it, and failed as a panic and anxiety treatment. |
| Gastrin | What it does: A related gut hormone that strongly activates CCK2. Where it matters most: Stomach and gut hormone system. Why you might care: Explains why CCK2 is sometimes called the gastrin receptor. Acid-reflux drugs act elsewhere and tell you nothing about your CCK2 activity. |
| Peptide-processing enzymes | What it does: Build and break down the different lengths of CCK. Where it matters most: Wherever CCK is released. Why you might care: Different CCK fragments, like CCK-4 versus longer forms, are not interchangeable, and no medicine simply raises or lowers all of them at once. |
What the panic challenge shows, and what it does not
CCK-4 is a short tail piece cut from the full CCK molecule. Given by injection, it reaches CCK2 and can trigger a fast burst of body and fear symptoms within a minute or two. People with panic disorder tend to be more sensitive to it in some studies, but the response also depends on the dose given, what the person expects to feel, their past panic history, their breathing pattern, and how sensitive their body-alarm system already is. All of that means the challenge is a useful research tool for studying a panic-like state on demand. It is not the same as measuring how much CCK a person’s own brain releases day to day, and it does not by itself explain why panic disorder develops in someone who was never given an injection.
That gap between a triggered lab response and an everyday illness is exactly where the CCK2-blocker story lands.
Why the CCK2-blocker drug failed
If panic disorder really came down to too much CCK2 activity, a drug that blocks CCK2 should calm it. That idea was tested with a compound called CI-988.
In a generalized anxiety disorder trial, CI-988 did not do better than placebo.4 In a panic disorder trial, it showed no difference from placebo in panic attacks, and the study was stopped early at an interim review, after only 41 people had enrolled.5 In a separate study, researchers gave CI-988 before a CCK-4 challenge to see if blocking the receptor first would prevent the panic response. It did not stop the triggered symptoms either.6
None of this erases the biology. CCK-4 reliably reaches fear and body-alarm pathways, and that remains a real, repeatable finding. What the CI-988 results show is that reaching a receptor and blocking it does not automatically translate into relief from a lasting illness. The trial that was stopped early, with only 41 people enrolled, also means the negative result came from a small sample, so it does not prove that every possible CCK2-targeting drug must fail.5 It does mean this particular idea, tested this way, did not pan out.
Sincalide, a lab-made CCK-like drug, is a separate story worth knowing about because it shows the same system used successfully, just for something else entirely. Sincalide is FDA-approved to trigger specific gut responses, such as gallbladder contraction, during certain diagnostic tests.78 It has real effects, including possible cramping or nausea tied to the procedure. It has no psychiatric use and is not an anxiety or panic medicine.
Can CCK be measured?
Not in a way that tells you anything useful about your mental health.
Plasma, or blood, tests can measure some CCK-like peptides. The result depends heavily on which form of CCK is being measured, when you last ate, how the sample was collected, and the exact test method. It mostly reflects what your gut and body are doing, not what CCK2 is doing in a fear circuit in your brain.
Spinal fluid and tissue measurements exist as research tools. They cannot show moment-to-moment release at one specific connection between two nerve cells, and they cannot explain why a particular symptom occurred.
The CCK-4 challenge itself is a research procedure, not a diagnostic test. It changes the system on purpose to study it. It is not used to choose a medicine, and a review of the model notes it has real limits for guiding panic-drug development even though it remains useful for research.1
No blood test, urine test, saliva test, brain scan, gene test, or challenge test can diagnose a person’s CCK state or tell a clinician which medicine to prescribe.
What each medicine actually touches
| Medicine or approach | What it does directly, used for, and main tradeoffs |
|---|---|
| Sincalide | What it does directly: A lab-made, CCK-like drug that strongly activates CCK1 in the body. Used for: Specific diagnostic gut tests, such as certain gallbladder studies. Main tradeoffs: Gut and, in some cases, heart effects tied to the procedure itself. Not for self-use, and not a psychiatric drug. |
| CI-988 | What it does directly: A drug built to block CCK2. Used for: Was tested for generalized anxiety disorder and panic disorder. Main tradeoffs: Did not outperform placebo in either trial, and did not block the CCK-4 panic response either. Never became an approved medicine. |
| Other CCK1 or CCK2 compounds | What it does directly: Various receptor activators or blockers used only in lab and animal research. Used for: Studying the receptor system itself. Main tradeoffs: Whether any of these reach the human brain in a meaningful way, and whether they would help mental health symptoms, remains unproven. |
| Current anxiety and depression medicines | What it does directly: Approved drugs that work through their own separate targets. Used for: Anxiety and depression, by their own approved indications. Main tradeoffs: Any downstream effect they might have on CCK is unclear or happens later in the chain. They should not be thought of as CCK medicines. |
None of today’s approved anxiety or depression medicines work by targeting CCK directly. If one of them happens to change a CCK-related measurement somewhere in the body, that is not the same as proof that CCK was the problem it fixed.
Which symptoms need a call, and which need urgent help
Track and mention at your next visit: mild nausea, appetite changes, occasional panic-like sensations, sleep changes, or digestive symptoms. Write down when they started, what you ate or what medicine change came before them, and how they affect your day.
Call the prescriber or pharmacist promptly: vomiting that will not stop, a major weight change, repeated panic-like episodes, medicine side effects that are hard to manage, a break in a prescription you were told to keep taking, or exposure to an unapproved peptide product marketed for CCK effects.
Call Poison Control at 1-800-222-1222 for a suspected medicine overdose, a mix-up, or a medicine taken the wrong way, even without severe symptoms yet. Do not wait for symptoms to appear before calling.
Call 911 now for breathing difficulty, seizure, collapse, inability to wake someone, severe confusion, or severe chest or heart symptoms. For a suicidal or mental health crisis, call or text 988. If danger is immediate, call 911 first. A call to Poison Control or a routine prescriber call should never delay a 911 call in an emergency.
Because no direct CCK-targeting drug is approved for any mental health condition, there is no labeled psychiatric safety warning tied to one. Sincalide carries its own separate, nonpsychiatric safety information and is only given under supervised clinical care.
What to ask your prescriber
These are conversation starters, not instructions.
- What symptom or problem is this medicine actually meant to change?
- Does it act on CCK at all, or is that not part of how it works?
- What improvement should we look for first, and by when?
- Which nausea, appetite, anxiety, or other effects should prompt a call rather than waiting for the next visit?
- Are there risks from mixing this with other prescriptions, over-the-counter drugs, supplements, alcohol, cannabis, nicotine, or caffeine?
- What should I do if I miss a dose?
- Could stopping this medicine suddenly cause withdrawal, rebound, or a return of my symptoms?
- Is a product or test marketed as measuring or changing my CCK level actually FDA-authorized for that use?
Bottom line
A panic attack does not mean your CCK is too high, and a CCK-blocking drug does not exist as a mental health treatment because the one that was tried did not work. Dopamine works the same way and your brain is not a gas tank for the same reason: a chemical having an effect in a lab challenge does not mean an everyday illness comes from too much or too little of that chemical. What CCK research does show clearly is how a gut hormone and a nerve signal can share a name and still do very different jobs depending on where they act. Ask what a medicine actually touches, what to watch for, and what to do if something goes wrong. That is a more useful conversation than trying to reason your way to a chemical cause.
Frequently asked questions
Does panic disorder mean I have too much CCK?
No. CCK-4 can trigger panic-like symptoms in a controlled research setting, but that challenge does not diagnose the cause of panic disorder as it happens in everyday life.
If the challenge works, why did the blocker fail as a treatment?
Triggering a symptom on purpose and treating a lasting illness are different tests. How much of the drug reached the brain, which other receptors it touched, how the study was run, and timing all matter, and any of those could explain the gap.
Does feeling hungry mean my CCK is low?
No. Hunger and fullness come from a mix of gut stretch, nutrients, several hormones, learned habits, sleep, stress, medicine effects, and whether food is available. CCK is one input among many.
Can a blood test show what CCK is doing in my brain?
No. A blood CCK level mostly reflects gut activity. It cannot show what is happening at a receptor in a living brain circuit.
Is sincalide an anxiety medicine?
No. It is a prescription drug used for specific gut diagnostic tests. It has no approved mental health use.
Are today’s anxiety medicines secretly CCK treatments?
Not in any proven sense. Even if a medicine changes a CCK-related marker somewhere in the body later on, that does not make CCK its actual target.
Can supplements that claim to raise or lower CCK treat panic?
No responsible care advice follows from that idea. Supplements affect more than one system in the body and can interact with medicines you already take.
Can a genetic test measure my CCK activity?
No. A gene test cannot show how much CCK your body is releasing right now, and it cannot choose a mental health medicine for you.
Related reading on NP FADY
- Your Brain Is Not a Gas Tank (start here)
- Why an Antidepressant Would Block an Excitement Signal
- The Resilience Chemical Nobody Can Measure
- Buspirone (BuSpar) for Anxiety: How It Works, Side Effects, and How It Compares
References
1. Kellner. Review of the CCK-4 challenge model in panic research. 2011. PMID: 22275853
2. IUPHAR/BPS cholecystokinin receptor record. Guide to Pharmacology. Accessed August 31, 2026. https://www.guidetopharmacology.org/GRAC/FamilyIntroductionForward?familyId=15
3. History and evidence review of cholecystokinin receptors. 2021. https://doi.org/10.3390/molecules26185657
4. CI-988 generalized anxiety disorder trial. PMID: 8748432
5. CI-988 panic disorder trial, stopped at interim review with 41 participants enrolled. https://doi.org/10.1016/S0006-3223(99)00090-6
6. CI-988 pretreatment trial against the CCK-4 panic challenge. https://doi.org/10.1007/s002130050186
7. Kinevac (sincalide) prescribing information. DailyMed. Accessed August 31, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1408aabb-6982-48e5-ae9f-504ec43b0003
8. Sincalide clinical pharmacology review, NDA 210850. U.S. Food and Drug Administration. Accessed August 31, 2026. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/210850Orig1s000ClinPharmR.pdf
This article is general education. It is not a diagnosis or a treatment plan. Do not start, stop, or change a medicine because of something you read here. Review every prescription, supplement, and substance with your prescriber or pharmacist.
If you or someone you know is in crisis
- Call 911 or go to your nearest emergency room for any life-threatening emergency.
- 988 Suicide & Crisis Lifeline — call or text 988, available 24/7. En español: marque 988 y oprima 2. Veterans: 988 and press 1, or text 838255.
- Crisis Text Line — text HOME to 741741.
- The Trevor Project (crisis support for LGBTQ+ young people) — call 1-866-488-7386, or text START to 678-678.
- National Sexual Assault Hotline (RAINN) — call 1-800-656-HOPE (4673) or text HOPE to 64673; free, confidential, 24/7. Online chat at RAINN.org/hotline.
- National Domestic Violence Hotline — call 1-800-799-SAFE (7233) or text START to 88788; 24/7, help in 200+ languages. Online chat at TheHotline.org. If your phone or computer may be monitored, calling from a safer device is an option.
- Riverside County — Inland SoCal Crisis Helpline 951-686-HELP (4357), 24/7 (Inland SoCal United Way / 211+, in partnership with RUHS-BH); Community Access, Referral, Evaluation and Support (CARES) Line 800-499-3008, 24/7.
- San Bernardino County — Access Unit (Behavioral Health Helpline) 888-743-1478, 24/7; Mobile Crisis/CCRT 800-398-0018 (24/7, all ages) or text 909-420-0560. Arrowhead Regional Medical Center (ARMC) has a dedicated walk-in adolescent psychiatric ER (ages 13–17).
- Children under 13 — call 911 for immediate danger, contact your county's mobile crisis team (they respond to all ages), or go to the nearest pediatric emergency room.
- California Peer-Run Warm Line (non-crisis — someone to talk to) — call or text 1-855-600-WARM (9276); daytime and evening hours, not a 24/7 line.
- NP Fady (non-emergency) — for routine scheduling or questions, call (909) 707-6261. This line is not monitored for emergencies.